Table 1.
Baseline clinical parameters and laboratory test results of the first study
Parameters | All patients (n=78) | Patients in the 1st quartile (n=20) | Patients in the 4st quartile (n=20) | p-value 1st vs 4th quartile |
---|---|---|---|---|
Age (years) (mean±SD) | 59 ± 14 | 59 ± 13 | 59 ± 11 | 0.65 |
Sex (% male) | 69 | 70 | 75 | 1.00 |
Systolic BP (mmHg) (mean±SD) | 122 ± 23 | 128 ± 26 | 131 ± 21 | 0.33 |
Diastolic BP (mmHg) (mean±SD) | 66 ± 12 | 68 ± 13 | 67 ± 9 | 0.11 |
Total Cholesterol (mg/dl) (mean±SD) | 202 ± 14 | 193 ± 53 | 208 ± 51 | 0.92 |
LDL (mg/dl) (mean±SD) | 143 ± 39 | 138 ± 42 | 144 ± 36 | 0.53 |
HDL (mg/dl) (mean±SD) | 49 ± 14 | 46 ± 14 | 49 ± 11 | 0.22 |
Triglyceride (mg/dl) (median, range) | 120 (35 –664) | 102 (35 –664) | 104 (59 –656) | 0.93 |
CRP (mg/l) (mean±SD) | 13 ± 29 | 29 ± 53 | 6 ± 7 | 0.09 |
Creatinine (μmol/l) (median, range) | 84 (36 – 706) | 81 (52 – 120) | 93 (64 – 706) | 0.02 |
Hb (g/dl) (mean±SD) | 14 ± 1.4 | 14.0 ± 1.5 | 13.9 ± 1.4 | 0.92 |
Leukocytes (tsd/μl) (mean±SD) | 7.7 ± 2.8 | 8.3± 4.4 | 7.8 ± 2.3 | 0.57 |
Platelets (tsd/μl) (median, range) | 217 (90–445) | 214 (104–257) | 220 (113–306) | 0.66 |
BMI: body mass index; HR: heart rate; BP: blood pressure; LDL: low-density lipoprotein; HDL: high-density lipoprotein; CRP: C-reactive protein; Hb: hemoglobin;